Matinas BioPharma Holdings Inc.
11/06/2025 | Press release | Archived content
XBRL Q3 2025
Quarterly report [Sections 13 or 15(d)]
Cover
|
Cover - $ / shares |
9 Months Ended | |
|---|---|---|
|
Sep. 30, 2025 |
Nov. 06, 2025 |
|
| Cover [Abstract] | ||
| Document Type | 10-Q | |
| Amendment Flag | false | |
| Document Quarterly Report | true | |
| Document Transition Report | false | |
| Document Period End Date | Sep. 30, 2025 | |
| Document Fiscal Period Focus | Q3 | |
| Document Fiscal Year Focus | 2025 | |
| Current Fiscal Year End Date | --12-31 | |
| Entity File Number | 001-38022 | |
| Entity Registrant Name | MATINAS BIOPHARMA HOLDINGS, INC. | |
| Entity Central Index Key | 0001582554 | |
| Entity Tax Identification Number | 46-3011414 | |
| Entity Incorporation, State or Country Code | DE | |
| Entity Address, Address Line One | 1545 Route 206 South | |
| Entity Address, Address Line Two | Suite 302 | |
| Entity Address, City or Town | Bedminster | |
| Entity Address, State or Province | NJ | |
| Entity Address, Postal Zip Code | 07921 | |
| City Area Code | 908 | |
| Local Phone Number | 484-8805 | |
| Title of 12(b) Security | Common Stock | |
| Trading Symbol | MTNB | |
| Security Exchange Name | NYSE | |
| Entity Current Reporting Status | Yes | |
| Entity Interactive Data Current | Yes | |
| Entity Filer Category | Non-accelerated Filer | |
| Entity Small Business | true | |
| Entity Emerging Growth Company | false | |
| Entity Shell Company | false | |
| Entity Common Stock, Shares Outstanding | 6,406,191 | |
| Entity Listing, Par Value Per Share | $ 0.0001 |
Matinas BioPharma Holdings Inc. published this content on November 06, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 10, 2025 at 21:48 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]